Cardiff, UK, and Baltimore, U.S., January 29, 2018 – TrakCel, the software developer for cell and gene therapy supply chain tracking and orchestration systems, and
MENLO PARK–(BUSINESS WIRE)—October 31, 2018—Akoya Biosciences (Akoya), a Telegraph Hill Partners (THP) company, has acquired PerkinElmer, Inc’s Quantitative Pathology Solutions (QPS) portfolio. Akoya was founded
SAN DIEGO, Calif., and GUANGZHOU, China, Wednesday, October 24, 2018 – Agena Bioscience (Agena) and DaRui Biotechnology (DaRui) announced today that the MassARRAY System has
The panel accurately and sensitively detects over 1600 variants of clinical significance AUSTIN, Texas — Asuragen, Inc., a molecular diagnostics company delivering high-quality, easy to
Carlsbad, CA, 07/11/18– Argonaut Manufacturing Services, a contract development and manufacturing organization (CDMO) serving molecular diagnostic and biopharmaceutical companies, today announced it has reached a
First Contract Development & Manufacturing Organization to Install Carterra’s Next Generation Label-Free Biosensor to Support Antibody Discovery Services Business Salt Lake City, UT, USA and
Seattle, WA, April 16, 2018 – RareCyte, Inc., a global rare cell detection and liquid biopsy company announces its newest product, CyteFinder HT in conjunction
SAN DIEGO, Calif., and NANJING, JiangSu, March 26, 2018 – Agena Bioscience (Agena) and Simcere Diagnostics (Simceredx), the subsidiary of SIMCERE Pharmaceutical Group, announced today
Salt Lake City, Utah, USA… Carterra Inc., an innovative label-free biosensor company, announced today that it has sold multiple units of its new, fully integrated,
Additional Resources Will Drive Commercialization of Novel High-Throughput Label-Free Biosensor for Streamlined Antibody Characterization Salt Lake City, Utah, USA…Carterra Inc., an innovative label-free biosensor
AUSTIN, Texas– Asuragen, Inc., a global molecular diagnostics product company changing the way patients are treated in genetics and oncology by bringing complex molecular tests
October 24, 2017 Ann Arbor, MI: Aquaro Histology, Inc. (formerly known as Aquaro Biosystems, LLC) announced today the completion of a Series A funding round
This website uses cookies and similar technologies to support basic site functionality and help us understand how visitors use the site. We use analytics tools such as Google Analytics, to improve website performance and content.We do not sell personal information or use cookies for targeted advertising.You can accept all cookies, reject non-essential cookies, or adjust your preferences at any time. For more information, please review our Privacy Policy.
Essential cookies and services enable basic functions and are necessary for the proper functioning of the website.
This category includes all cookies, domains, and services that do not fall into the other specified categories or have not been explicitly categorized.
This website uses cookies to enhance your browsing experience and ensure the site functions properly. By continuing to use this site, you acknowledge and accept our use of cookies.
